The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks
Abstract
Aims Blood pressure variability is associated with increased risk of cardiovascular events, particularly in high-risk patients. We assessed if variability was associated with increased risk of cardiovascular events and death in hypertensive patients at different risk levels. Methods and results The Valsartan Antihypertensive Long-term Use Evaluation trial was a randomized controlled trial of valsartan vs. amlodipine in patients with hypertension and different risks of cardiovascular events, followed for a mean of 4.2 years. We calculated standard deviation (SD) of mean systolic blood pressure from visits from 6 months onward in patients with ≥3 visits and no events during the first 6 months. We compared the risk of cardiovascular events in the highest and lowest quintile of visit-to-visit blood pressure variability, using Cox regression. For analysis of death, variability was analysed as a continuous variable. Of 13 803 patients included, 1557 (11.3%) had a cardiovascular event and 1089 (7.9%) died. Patients in the highest quintile of SD had an increased risk of cardiovascular events [hazard ratio (HR) 2.1, 95% confidence interval (95% CI) 1.7-2.4; P Conclusion Higher visit-to-visit systolic blood pressure variability is associated with increased risk of cardiovascular events in patients with hypertension, irrespective of baseline risk of cardiovascular events. Associations were stronger in younger patients and in those with lower mean systolic blood pressure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the VALUE trial75, a higher visit-to-visit systolic BPV was associated with increased risk of cardiovascular events in patients with hypertension, irrespective of baseline cardiovascular risk, and this association was stronger in younger patients and those with lower systolic BP levels.”
From Blood pressure and its variability: classic and novel measurement techniques (2022) · cites this paper as [75]
Citations
Cites
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Self-citationMancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Self-citationJulius, S., Kjeldsen, S. E., Weber, M., Brunner, H. R., Ekman, S., Hansson, L., Hua, T., Laragh, J., McInnes, G. T., Mitchell, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16451-9 · Cited by 2,558
Self-citationAortic Pulse Wave Velocity Improves Cardiovascular Event Prediction
Ben-Shlomo, Y., Spears, M., Boustred, C., May, M., Anderson, S. G., Benjamin, E. J., Boutouyrie, P., Cameron, J., Chen, C.-H., Cruickshank, J. K., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.063 · Cited by 1,835
Rothwell, P. M., Howard, S. C., Dolan, E., O'Brien, E., Dobson, J. E., Dahlöf, B., Sever, P. S., & Poulter, N. R. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60308-x · Cited by 1,784 · cited 10×
“Similar to the findings of a stronger association between blood pressure variability and risk in younger people, we found that the increase in risk was steeper among patients with a lower systolic blood pressure during follow-up.(4,8) Again, one interpretation is that patients with lower blood pressure are more vulner…”
BackgroundMethodResultInfluentialSelf-citationBlood pressure variability and cardiovascular disease: systematic review and meta-analysis
Stevens, S. L., Wood, S., Koshiaris, C., Law, K., Glasziou, P., Stevens, R. J., & McManus, R. J. (2016) · BMJ · doi:10.1136/bmj.i4098 · Cited by 871
Assessment and management of blood-pressure variability
Parati, G., Ochoa, J. E., Lombardi, C., & Bilo, G. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.1 · Cited by 853
Self-citationMancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., Backer, G. D., Dominiczak, A. F., et al. (n.d.) · Open Access CRIS of the University of Bern · doi:10.7892/boris.41664 · Cited by 742
Self-citation
Cited by
Blood pressure and its variability: classic and novel measurement techniques
Schutte, A. E., Kollias, A., & Stergiou, G. S. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00690-0 · Cited by 335
Blood pressure variability: its relevance for cardiovascular homeostasis and cardiovascular diseases
Parati, G., Torlasco, C., Pengo, M., Bilo, G., & Ochoa, J. E. (2020) · Hypertension Research · doi:10.1038/s41440-020-0421-5 · Cited by 137
Self-citationYang, L., Li, J., Wei, W., Pu, Y., Zhang, L., Cui, T., Ma, L., Wang, B., Zhao, Y., & Fu, P. (2023) · Journal of General Internal Medicine · doi:10.1007/s11606-022-08001-6 · Cited by 31
Nuyujukian, D. S., Zhou, J. J., Koska, J., & Reaven, P. D. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002931 · Cited by 14
Metadata
- Authors
- Mehlum, M. H., Liestøl, K., Kjeldsen, S. E., Julius, S., Hua, T. A., Rothwell, P. M., Mancia, G., Parati, G., Weber, M. A., & Berge, E.
- Affiliations
- Oslo University Hospital (NO)
- University of Oslo (NO)
- University of Michigan (US)
- Novartis (United States) (US)
- John Radcliffe Hospital (GB)
- University of Milano-Bicocca (IT)
- IRCCS Istituto Auxologico Italiano (IT)
- State University of New York (US)
- Corresponding author
- Berge, Eivind
- ORCID
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-01-20
- Volume
- 39
- Issue
- 24
- Pages
- 2243-2251
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2788982091
- Cited by
- 227
- References
- 35
- Citations by year
- 2026: 11 · 2025: 31 · 2024: 24 · 2023: 25 · 2022: 28 · 2021: 43 · 2020: 29 · 2019: 24 · 2018: 11
- FWCI
- 13.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Funders
- Norwegian ExtraFoundation
- Norwegian Health Association
- Novartis Pharma AG
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Keywords
- blood pressure variability, hypertension, cardiovascular events, cardiovascular mortality, baseline cardiovascular risk, valsartan, amlodipine, antihypertensive therapy, established cardiovascular disease, young patients
- MeSH terms
- Valsartan, Aged, Antihypertensive Agents, Blood Pressure, Female, Heart Failure, Humans, Hypertension, Male, Middle Aged, Mortality, Myocardial Infarction, Prognosis, Proportional Hazards Models, Amlodipine, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks. https://app.cochat.ai/papers/10.1093/eurheartj/ehx760
- The paper
- Mehlum, M. H., Liestøl, K., Kjeldsen, S. E., Julius, S., Hua, T. A., Rothwell, P. M., Mancia, G., Parati, G., Weber, M. A., & Berge, E. (2018). Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks. European Heart Journal. https://doi.org/10.1093/eurheartj/ehx760
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.